Medpace Holdings, Inc. MEDP
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 716.00M | 707.33M | 706.60M | 708.45M | 659.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 716.00M | 707.33M | 706.60M | 708.45M | 659.90M |
| Cost of Revenue | 204.85M | 202.56M | 198.27M | 182.15M | 186.34M |
| Gross Profit | 511.15M | 504.78M | 508.33M | 526.30M | 473.57M |
| SG&A Expenses | 51.77M | 48.10M | 47.92M | 44.92M | 48.08M |
| Depreciation & Amortization | 6.58M | 6.71M | 6.91M | 7.13M | 7.05M |
| Other Operating Expenses | 287.26M | 303.14M | 312.00M | 320.98M | 276.63M |
| Total Operating Expenses | 550.46M | 560.51M | 565.10M | 555.18M | 518.10M |
| Operating Income | 165.54M | 146.82M | 141.50M | 153.27M | 141.81M |
| Income Before Tax | 170.91M | 151.66M | 147.59M | 156.83M | 142.84M |
| Income Tax Expenses | 33.45M | 30.30M | 23.72M | 21.70M | 31.70M |
| Earnings from Continuing Operations | 137.46M | 121.36M | 123.87M | 135.13M | 111.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 137.46M | 121.36M | 123.87M | 135.13M | 111.14M |
| EBIT | 165.54M | 146.82M | 141.50M | 153.27M | 141.81M |
| EBITDA | 172.12M | 153.53M | 148.41M | 160.40M | 148.86M |
| EPS Basic | 4.92 | 4.31 | 4.35 | 4.78 | 3.95 |
| Normalized Basic EPS | 3.82 | 3.36 | 3.24 | 3.46 | 3.17 |
| EPS Diluted | 4.84 | 4.25 | 4.28 | 4.66 | 3.86 |
| Normalized Diluted EPS | 3.76 | 3.32 | 3.19 | 3.38 | 3.10 |
| Average Basic Shares Outstanding | 27.94M | 28.17M | 28.45M | 28.29M | 28.14M |
| Average Diluted Shares Outstanding | 28.37M | 28.55M | 28.96M | 28.96M | 28.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |